Table 1 Baseline data and drug administration following acquisition of baseline dataa
From: Seeking a blood pressure-independent measure of vascular properties
Parameter | Fisher young (n=8) | Fisher old (n=7) | Pb | SHR young (n=5) | SHR old (n=6) | Pb |
|---|---|---|---|---|---|---|
Baseline values | ||||||
 SBP (mm Hg) | 124.3 (15.7) | 125.7 (21.5) | 0.91 | 124.1 (45.2) | 171.5 (12.7) | 0.035* |
 MAP (mm Hg) | 88.5 (11.0) | 87.2 (14.9) | 0.85 | 82.5 (31.5) | 123.3 (11.1) | 0.015* |
 DBP (mm Hg) | 87.0 (10.9) | 84.0 (14.6) | 0.67 | 79.8 (31.6) | 120.9 (11.2) | 0.015* |
 HR (mm Hg) | 320.1 (21.9) | 272.9 (35.1) | 0.007* | 353.7 (58.6) | 356.2 (46.7) | 0.94 |
 PP (mm Hg) | 37.4 (5.3) | 41.3 (7.4) | 0.25 | 44.2 (15.1) | 50.6 (4.1) | 0.35 |
 PWV (m s−1) | 3.69 (0.28) | 4.12 (0.79) | 0.17 | 4.12 (0.06) | 5.87 (0.85) | 0.004* |
DBP (mm Hg) at | ||||||
 Onset of measurements | 135.6 (2.2) | 140.3 (3.9) | 0.57 | 148.5 (19.1) | 147.3 (6.61) | 0.89 |
 Middle of measurement | 115.0 (5.2) | 104.8 (13.9) | 0.07 | 113.2 (26.6) | 121.0 (12.1) | 0.54 |
 Last measurement | 77.2 (7.2) | 68.3 (17.2) | 0.20 | 61.5 (9.5) | 95.2 (19.4) | <0.0001* |
Total phenylephrine dose (mcg) | 14.7 (3.7) | 38.2 (25.5) | 0.022* | 9.2 (3.2) | 7.6 (4.5) | 0.52 |
